BTT-3033

• Description:

  BTT-3033 is an orally active and potent α2β1 (EC50: 130 nM) inhibitor with an affinity for the α2I domain, inhibiting platelet binding to collagen I and cell proliferation. BTT-3033 induces apoptosis and can be used to study prostate cancer, inflammation, and cardiovascular disease.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  465.5

• Molecular Formula:

  C23H20FN5O3S

• Notes:

  Research use only, not for human use.

• Receptor:

  Apoptosis | Integrin

• CAS Number:

  1259028-99-3